Rigel Pharmaceuticals, Inc.
RIGL
$19.41
$0.130.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.34M | 12.42M | -1.03M | -8.25M | 737.00K |
| Total Depreciation and Amortization | 604.00K | 611.00K | 613.00K | 400.00K | 293.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.76M | 2.55M | 2.37M | 4.93M | 1.56M |
| Change in Net Operating Assets | -2.20M | 6.10M | -1.65M | -2.10M | -8.83M |
| Cash from Operations | 14.50M | 21.68M | 302.00K | -5.01M | -6.24M |
| Capital Expenditure | -26.00K | -10.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 72.00K | 26.00K | -- | -- | 110.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.96M | 3.79M | 10.93M | 313.00K | -6.98M |
| Cash from Investing | -10.91M | 3.80M | 10.93M | 313.00K | -6.87M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.47M | 158.00K | 252.00K | 89.00K | 486.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -10.00M | -1.00M | -2.60M | 0.00 |
| Cash from Financing | 1.47M | -9.84M | -752.00K | -2.51M | 486.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.05M | 15.64M | 10.48M | -7.21M | -12.63M |